Evidence map›Paper›PMID 40297821›Full record

ArticleTherapeutic advances in neurological disorders2025

Association of CT perfusion parameters with outcomes in patients with medium vessel occlusion undergoing endovascular thrombectomy.

Yoel Schwartzmann, Hamza Joubran, Tamer Jubeh, Issa Metanis, Aviva Alpernas, Tali Jonas-Kimchi, Udi Sadeh, John M Gomori, Jose E Cohen, Hen Hallevi and 2 more

Abstract read
In one paragraph

Article in Therapeutic advances in neurological disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yoel SchwartzmannDepartment of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.ORCID https://orcid.org/0000-0003-4459-6996
Hamza JoubranDepartment of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Tamer JubehDepartment of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Issa MetanisDepartment of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Aviva AlpernasDepartment of Stroke and Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Tali Jonas-KimchiDepartment of Radiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Udi SadehDepartment of Radiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
John M GomoriDepartment of Radiology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Jose E CohenDepartment of Neurosurgery, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Hen HalleviDepartment of Stroke and Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Jeremy MoladDepartment of Stroke and Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Ronen R LekerDepartment of Neurology, Hadassah-Hebrew University Medical Center, P.O. Box 12000, Jerusalem 91120, Israel.ORCID https://orcid.org/0000-0003-4794-0334

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Imaging biomarkers obtained on computed tomography perfusion (CTP) have proven effective in predicting outcomes after endovascular thrombectomy (EVT) in patients with large vessel occlusion stroke. However, the association of CTP imaging biomarkers with outcomes in medium-size vessel occlusion (MeVO) stroke patients remains unknown. Objectives: Therefore, we aimed to explore whether CTP parameters can be used for selection of a subset of MeVO patients that are more likely to benefit from EVT. Methods: Consecutively enrolled acute MeVO stroke patients treated with EVT were included. All patients underwent CTP on admission and follow-up noncontrast CT 24 h post-EVT. CTP parameters including core and penumbra volumes were obtained. Excellent outcome, defined as a modified Rankin score of 0-1 at 90 days poststroke was the primary outcome, and survival at 90 days was the safety outcome. Regression analyses were performed to examine the associations between different CTP parameters and outcomes. Results: Overall, 70 patients with MeVO were included (47% male, median age 75), and 66 (94%) had long-term follow-up data. Of those included, 26 patients (39%) had excellent outcomes and 2 (3%) had symptomatic intracerebral hemorrhage. On regression analysis, hypoperfused volumes on CTP were associated with excellent outcomes (adjusted odds ratio (aOR) 1.02, 95% confidence intervals (CI) 1.001-1.037), whereas core volume was not. Other factors associated with excellent outcome included admission National Institutes of Health Stroke Scale score (aOR 0.85, 95% CI 0.73-0.98) and lack of hypertension (aOR 0.07, 95% CI 0.07-0.62). Core or penumbral volumes were not associated with survival. Conclusion: Higher volumes of hypoperfused tissue on CTP are associated with a higher likelihood of excellent outcome. Core and penumbral volumes are not associated with increased mortality in patients with MeVO that undergo EVT.

Indexed as

CTPMeVOstroke

Identifiers

PMID40297821
PMCPMC12035288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.